{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:44:23Z","timestamp":1792525463949,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.surg.2026.110720","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:08:19Z","timestamp":1790687299000},"page":"110720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amplification of interferon-\u03b3-driven proinflammatory macrophage responses by granulocyte-macrophage colony-stimulating factor: Implications for colorectal cancer immunotherapy"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0350-8822","authenticated-orcid":false,"given":"Shalmali","family":"Dharmadhikari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brayden","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Gable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoudao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9994-5263","authenticated-orcid":false,"given":"Susan","family":"Galandiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2026.110720_bib1","article-title":"Colorectal cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.surg.2026.110720_bib2","article-title":"Immune checkpoint blockade therapies for colorectal cancer: current strategies and emerging approaches","volume":"2","author":"Pum","year":"2025","journal-title":"JCO Oncol Adv"},{"key":"10.1016\/j.surg.2026.110720_bib3","article-title":"Deficient mismatch repair\/microsatellite instability-high colorectal cancer: current treatment paradigms, limitations and future perspectives","volume":"5","author":"Storandt","year":"2026","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.surg.2026.110720_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1433315","article-title":"Immunotherapy for colorectal cancer","volume":"15","author":"Yu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.surg.2026.110720_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1753180","article-title":"Unveiling the tumor microenvironment in colorectal cancer therapeutic resistance","volume":"13","author":"Han","year":"2026","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.surg.2026.110720_bib6","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.3390\/ijms22168470","article-title":"Tumor-associated macrophages (TAMs) in colorectal cancer (CRC): from mechanism to therapy and prognosis","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.surg.2026.110720_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/imm.13952","article-title":"The landscape of SPP1+ macrophages across tissues and diseases: a comprehensive review","volume":"176","author":"Palma","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.surg.2026.110720_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251316604","article-title":"Macrophage polarisation in the tumour microenvironment: recent research advances and therapeutic potential of different macrophage reprogramming","volume":"32","author":"Guo","year":"2025","journal-title":"Cancer Control"},{"key":"10.1016\/j.surg.2026.110720_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.surg.2026.110720_bib10","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3389\/fimmu.2019.01875","article-title":"The two faces of tumor-associated macrophages and their clinical significance in colorectal cancer","volume":"10","author":"Pinto","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.surg.2026.110720_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1732718","article-title":"Macrophage polarization: molecular mechanisms, disease implications, and targeted therapeutic strategies","volume":"16","author":"Ji","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.surg.2026.110720_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109569","article-title":"Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: current research in Macrophage repolarization immunotherapy","volume":"116","author":"Cheruku","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.surg.2026.110720_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/2326-6066.CIR-20-0527","article-title":"The prognostic role of macrophage polarization in the colorectal cancer microenvironment","volume":"9","author":"V\u00e4yrynen","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.surg.2026.110720_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.surg.2026.110720_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.surg.2026.110720_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1189\/jlb.3RU0316-144R","article-title":"Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage","volume":"100","author":"Ushach","year":"2016","journal-title":"J Leucocyte Biol"},{"key":"10.1016\/j.surg.2026.110720_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s12264-020-00493-8","article-title":"SOCS3 attenuates GM-CSF\/IFN-\u03b3-mediated inflammation during spontaneous spinal cord regeneration","volume":"36","author":"Zhang","year":"2020","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.surg.2026.110720_bib18","doi-asserted-by":"crossref","first-page":"21172","DOI":"10.1002\/cam4.6681","article-title":"Anti-inflammatory mechanisms in cancer research: characterization of a distinct M2-like macrophage model derived from the THP-1 cell line","volume":"12","author":"Scheurlen","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.surg.2026.110720_bib19","article-title":"Macrophage differentiation and polarization into an M2-like phenotype using a human monocyte-like THP-1 leukemia cell line","volume":"2","author":"Scheurlen","year":"2021","journal-title":"JoVE"},{"key":"10.1016\/j.surg.2026.110720_bib20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaci.2023.04.022","article-title":"The regulatory landscape of macrophage interferon signaling in inflammation","volume":"152","author":"Siebeler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.surg.2026.110720_bib21","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.178.8.5245","article-title":"Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation","volume":"178","author":"Fleetwood","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.surg.2026.110720_bib22","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0400983101","article-title":"Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco) bacteria","volume":"101","author":"Verreck","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.surg.2026.110720_bib23","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/s41592-025-02861-6","article-title":"nELISA: a high-throughput, high-plex platform enables quantitative profiling of the inflammatory secretome","volume":"22","author":"Dagher","year":"2025","journal-title":"Nat Methods"},{"key":"10.1016\/j.surg.2026.110720_bib24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s12276-020-0436-7","article-title":"The FBW7-MCL-1 axis is key in M1 and M2 macrophage-related colon cancer cell progression:validating the immunotherapeutic value of targeting PI3K\u03b3","volume":"52","author":"Lee","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.surg.2026.110720_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3892\/ijo.2013.2203","article-title":"Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2","volume":"44","author":"Engstr\u00f6m","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.surg.2026.110720_bib26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.immuni.2016.10.026","article-title":"GM-CSF: from growth factor to central mediator of tissue inflammation","volume":"45","author":"Becher","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.surg.2026.110720_bib27","article-title":"GM-CSF in inflammation","volume":"217","author":"Hamilton","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.surg.2026.110720_bib28","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1172\/JCI87828","article-title":"Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation","volume":"126","author":"Achuthan","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.surg.2026.110720_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ni.1990","article-title":"IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses","volume":"12","author":"Krausgruber","year":"2011","journal-title":"Nat Immunol"},{"issue":"Supplement_1","key":"10.1016\/j.surg.2026.110720_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jimmun\/vkaf283.1568","article-title":"Targeting GM-CSF\u2013IRF5 signaling pathway ameliorates TLR7 overexpression-induced macrophage activation syndrome 3809","volume":"214","author":"Huang","year":"2025","journal-title":"J Immunol"},{"key":"10.1016\/j.surg.2026.110720_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.immuni.2006.02.014","article-title":"IFN-\u03b3 suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB\/AP-1 proteins","volume":"24","author":"Hu","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.surg.2026.110720_bib32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.102659","article-title":"Reprogramming of GM-CSF-dependent alveolar macrophages through GSK3 activity modulation","volume":"14","author":"R\u00edos","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.surg.2026.110720_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.ade2292","article-title":"CXCL9: SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.surg.2026.110720_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/jir.2022.0132","article-title":"IFN-\u03b3 and TGF-\u03b2, crucial players in immune responses: a tribute to Howard Young","volume":"42","author":"Gauthier","year":"2022","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.surg.2026.110720_bib35","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1038\/s41598-024-84969-x","article-title":"The role of IFN-\u03b3\/CXCL10 axis in Mycoplasma pneumonia infection","volume":"15","author":"Zou","year":"2025","journal-title":"Scientific Rep"},{"key":"10.1016\/j.surg.2026.110720_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116930","article-title":"Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials","volume":"177","author":"Zhang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.surg.2026.110720_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.21873\/cgp.20429","article-title":"CXCL10 expression in human colorectal cancer tissue and its correlation with serum levels of CXCL10","volume":"21","author":"Li","year":"2024","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.surg.2026.110720_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16080-y","article-title":"GM-CSF derived from the inflammatory microenvironment potentially enhanced PD-L1 expression on tumor-associated macrophages in human breast cancer","volume":"12","author":"Yonemitsu","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.surg.2026.110720_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/10732748261430581","article-title":"Research progress on tumor-associated macrophages and PD-1\/PD-L1 inhibitors in advanced colorectal cancer","volume":"33","author":"Ning","year":"2026","journal-title":"Cancer Control"},{"key":"10.1016\/j.surg.2026.110720_bib40","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s41416-023-02238-6","article-title":"Spatially resolved multimarker evaluation of CD274 (PD-L1)\/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer","volume":"128","author":"Elomaa","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surg.2026.110720_bib41","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3390\/molecules30132686","article-title":"Focus on pd-1\/pd-L1-targeting antibodies in colorectal cancer: are there options beyond dostarlimab, nivolumab, and pembrolizumab? A comprehensive review","volume":"30","author":"Kciuk","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.surg.2026.110720_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.54457\/DR.202401005","article-title":"Interferons in colorectal cancer pathogenesis and therapy","volume":"4","author":"Petrova","year":"2024","journal-title":"Dis Res"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026006458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026006458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:22:22Z","timestamp":1792524142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606026006458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S0039606026006458"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2026.110720","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amplification of interferon-\u03b3-driven proinflammatory macrophage responses by granulocyte-macrophage colony-stimulating factor: Implications for colorectal cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2026.110720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110720"}}